EMEA-002233-PIP01-17-M02 - paediatric investigation plan

Dasiglucagon

Key facts

• Active Substance:
  Dasiglucagon
• Therapeutic area:
  Endocrinology-Gynaecology-Fertility-Metabolism
• Decision number:
  P/0176/2023
• PIP number:
  EMEA-002233-PIP01-17-M02
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of hypoglycaemia
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  15/05/2023

Decision

P/0176/2023: EMA decision of 15 May 2023 on the acceptance of a modification of an agreed paediatric investigation plan for dasiglucagon (EMEA- 002233-PIP01-17-M02)

Reference Number: EMA/177613/2023